Bausch Health Cos Debt to Equity Ratio 2010-2024 | BHC

Current and historical debt to equity ratio values for Bausch Health Cos (BHC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bausch Health Cos debt/equity for the three months ending September 30, 2024 was 0.00.
Bausch Health Cos Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $26.78B $-0.24B -110.67
2024-06-30 $26.72B $-0.23B -117.72
2024-03-31 $27.09B $-0.17B -155.67
2023-12-31 $27.43B $-0.08B -334.54
2023-09-30 $27.30B $-0.24B -116.17
2023-06-30 $25.23B $0.27B 93.11
2023-03-31 $25.30B $0.15B 174.48
2022-12-31 $25.43B $0.26B 97.79
2022-09-30 $25.87B $0.43B 59.73
2022-06-30 $27.92B $0.25B 110.35
2022-03-31 $29.23B $-0.14B -207.31
2021-12-31 $29.24B $-0.03B -859.88
2021-09-30 $29.39B $-0.14B -217.68
2021-06-30 $30.65B $-0.61B -50.17
2021-03-31 $30.32B $-0.12B -244.52
2020-12-31 $30.59B $0.61B 50.57
2020-09-30 $30.91B $0.66B 47.19
2020-06-30 $30.85B $0.55B 56.50
2020-03-31 $31.08B $0.79B 39.34
2019-12-31 $32.73B $1.14B 28.81
2019-09-30 $29.11B $2.56B 11.37
2019-06-30 $29.67B $2.69B 11.04
2019-03-31 $29.77B $2.78B 10.71
2018-12-31 $29.68B $2.82B 10.54
2018-09-30 $30.54B $3.24B 9.44
2018-06-30 $30.89B $3.56B 8.68
2018-03-31 $31.28B $4.52B 6.92
2017-12-31 $31.55B $5.94B 5.31
2017-09-30 $34.55B $5.42B 6.37
2017-06-30 $37.70B $4.03B 9.36
2017-03-31 $38.34B $3.99B 9.60
2016-12-31 $40.27B $3.26B 12.36
2016-09-30 $41.49B $4.27B 9.71
2016-06-30 $42.26B $5.40B 7.82
2016-03-31 $43.24B $5.78B 7.49
2015-12-31 $42.94B $6.03B 7.12
2015-09-30 $41.99B $6.47B 6.50
2015-06-30 $41.79B $6.56B 6.37
2015-03-31 $31.99B $6.58B 4.87
2014-12-31 $20.90B $5.40B 3.87
2014-09-30 $21.83B $5.23B 4.17
2014-06-30 $22.53B $5.37B 4.20
2014-03-31 $22.79B $5.20B 4.38
2013-12-31 $22.74B $5.23B 4.35
2013-09-30 $23.14B $5.06B 4.57
2013-06-30 $14.08B $5.70B 2.47
2013-03-31 $13.90B $3.59B 3.88
2012-12-31 $14.23B $3.72B 3.83
2012-09-30 $10.36B $3.79B 2.74
2012-06-30 $10.32B $3.70B 2.79
2012-03-31 $9.54B $4.08B 2.34
2011-12-31 $9.18B $3.93B 2.34
2011-09-30 $7.80B $4.01B 1.94
2011-06-30 $7.16B $4.67B 1.54
2011-03-31 $6.98B $4.71B 1.48
2010-12-31 $5.88B $4.91B 1.20
2010-09-30 $5.79B $5.35B 1.08
2010-06-30 $0.67B $1.36B 0.49
2010-03-31 $0.66B $1.34B 0.49
2009-12-31 $0.71B $1.35B 0.52
2009-09-30 $0.73B $1.29B 0.57
2009-06-30 $0.80B $1.25B 0.64
2009-03-31 $0.38B $1.18B 0.32
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00